References
- Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med 2007;356:213–15
- Gluckman PD, Hanson MA, Cooper C, et al. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med 2008;359:61–73
- Langley SC, McMullen S. Developmental origins of adult disease. Med Princ Pract 2010;19:87–98
- Zhu W, Yang H, Wei Y, et al. Comparing the diagnostic criteria for gestational diabetes mellitus of world health organization 2013 with 1999 in Chinese population. Chin Med J (Engl) 2015;128:125–7
- Miller RA, Chu Q, Xie J, et al. Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP. Nature 2013;494:256–60
- International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010;33:676–82
- Osgood ND, Dyck RF, Grassmann WK. The inter-and intragenerational impact of gestational diabetes on the epidemic of type 2 diabetes. Am J Publ Health 2011;101:173–9
- Nasu R, Seki K, Nara M, et al. Effect of a high-fat diet on diabetic mother rats and their offspring through three generations. Endocrine J 2007;54:563–9
- Van Assche FA, Holemans K, Aerts L. Long-term consequences for offspring of diabetes during pregnancy. Br Med Bull 2001;60:173–82
- Aerts L, Sodoyez-Goffaux F, Sodoyez JC, et al. The diabetic intrauterine milieu has a long lasting effect on insulin secretion by B cells and on insulin uptake by target tissues. Am J Obstet Gynecol 1988;159:1287–92
- Mather KJ, Goldberg RB. Clinical use of adiponectin as a marker of metabolic dysregulation. Best Pract Res Clin Endocrinol Metab 2014;28:107–17
- Inadera H. The useftilness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci 2008;5:248–62
- Okamoto Y, Kihara S, Funahashi T, et al. Adiponectin: a key adipocytokine in metabolic syndrome. Clin Sci (Lond) 2006;110:267–78
- Sheng TX, Yang KJ. Adiponectin and its association with insulin resistance and type 2 diabete. J Genet Genomics 2008;35:321–6
- Chalkley SM, Hettiarachchi M, Chisholm DJ, et al. Long-term high-fat feeding leads to severe insulin resistance but not diabetes in Wistar rats. Am J Physiol Endocrinol Metab 2002;282:1231–8
- Cooksey RC, McClain DA. Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway. Amino Acids 2011;40:841–6
- Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013;7:14–24
- Qi L, Rimm E, Liu S, et al. Dietary glycemic index, glycemic load, cereal fiber, and plasma adiponectin concentration in diabetic men. Diabetes Care 2005;28:1022–8
- Liu YM, Lacorte JM, Viguerie N, et al. Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short term very low calorie diet and refeeding. J Clin Endocrinol Metab 2003;88:5881–6
- Koo SH, Flechner L, Qi L, et al. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005;437:1109–11
- Yamauchi T, Nio Y, Maki T, et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med 2007;13:332–9
- Dzamko NL, Steinberg GR. AMPK-dependent hormonal regulation of whole-body energy metabolism. Acta Physiol 2009;196:115–27